FBD Holdings announces Emer Daly to its Board as upcoming independent Non-Executive Director

– IRELAND, Dublin – FBD Holdings plc is pleased to announce the appointment of Ms. Emer Daly to its Board which was approved at its meeting on 25 August 2014.

Ms. Emer Daly will join the Board with effect from 14 November 2014 as an independent non-executive Director.  Ms. Daly is a Fellow of Chartered Accountants Ireland and has valuable experience of the general insurance industry, having previously served as a Director with AXA in Ireland between 2000 and 2006 with responsibility for Financial Operations, Strategy and Risk Management.

Ms. Daly is currently a non-executive Director of Permanent TSB Group Holdings plc, and Permanent TSB plc where she also serves as Chairman of the Audit Committee.  She also serves as a non-executive Director of Friends Provident International Limited and Lombard S.A. and as Chairman of the Audit, Risk and Compliance Committee for both companies.

Prior to joining AXA Ireland, Ms. Daly worked in practice with PricewaterhouseCoopers in Dublin and New York.

Ms. Daly holds BA (Hons) in Economics and a Diploma in Corporate Governance from University College Dublin and is a Certified Bank Director.  She brings to FBD her extensive skills, expertise and experience in accounting, risk management and governance.

Commenting on this appointment, the Chairman, Mr. Michael Berkery, said: “I am very pleased to announce Emer’s appointment to the Board to take effect in November and I warmly welcome her to FBD.  I look forward greatly to her contribution to the Board’s business, and to the development of the Group”.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.